Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis

BACKGROUND: Mepolizumab (MPZ), an anti-interleukin-5 antibody, is effective for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). However, its effectiveness has not been adequately evaluated in real-world clinical practice. In this study, we assessed the effectiveness and safety...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Ueno, Masanobu, Miyagawa, Ippei, Nakano, Kazuhisa, Iwata, Shigeru, Hanami, Kentaro, Fukuyo, Shunsuke, Kubo, Satoshi, Miyazaki, Yusuke, Kawabe, Akio, Yoshinari, Hiroko, Nakayamada, Shingo, Tanaka, Yoshiya
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7962235/
https://ncbi.nlm.nih.gov/pubmed/33726827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02462-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars